Royal Bank Of Canada Ab Cellera Biologics Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 406,991 shares of ABCL stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
406,991
Previous 407,384
0.1%
Holding current value
$1.03 Million
Previous $1.06 Million
12.99%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$69.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$30.8 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$26.8 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$20 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$18.5 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $719M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...